The estimated Net Worth of Martin P Sutter is at least $85.6 Million dollars as of 17 February 2022. Mr. Sutter owns over 4,000 units of Abiomed stock worth over $49,681,198 and over the last 21 years he sold ABMD stock worth over $35,647,205. In addition, he makes $267,496 as Independent Director at Abiomed.
Martin has made over 16 trades of the Abiomed stock since 2008, according to the Form 4 filled with the SEC. Most recently he sold 4,000 units of ABMD stock worth $1,258,840 on 17 February 2022.
The largest trade he's ever made was exercising 37,000 units of Abiomed stock on 8 May 2018 worth over $571,280. On average, Martin trades about 2,073 units every 56 days since 2003. As of 17 February 2022 he still owns at least 130,390 units of Abiomed stock.
You can see the complete history of Mr. Sutter stock trades at the bottom of the page.
Martin P. Sutter serves as Independent Director of the Company. Mr. Sutter has been the Co-Founder and a Managing Director of EW Healthcare Partners, previously known as Essex Woodlands Health Ventures, a healthcare-focused growth equity firm. Educated in chemical engineering and finance, Mr. Sutter has more than 35 years of management experience in operations, marketing, finance and venture capital. Mr. Sutter holds a Bachelor of Science degree from Louisiana State University and a Master of Business Administration from the University of Houston.
As the Independent Director of Abiomed, the total compensation of Martin Sutter at Abiomed is $267,496. There are 12 executives at Abiomed getting paid more, with Michael Minogue having the highest compensation of $16,612,800.
Martin Sutter is 65, he's been the Independent Director of Abiomed since 2008. There are 4 older and 13 younger executives at Abiomed. The oldest executive at Abiomed Inc. is Jeannine Rivet, 72, who is the Independent Director.
Martin's mailing address filed with the SEC is 22 Cherry Hill Dr, Beverly, MA 01915, USA.
Over the last 21 years, insiders at Abiomed have traded over $148,507,587 worth of Abiomed stock and bought 232,354 units worth $4,276,073 . The most active insiders traders include Michael R Minogue, Eric A Md Rose und David M Weber. On average, Abiomed executives and independent directors trade stock every 16 days with the average trade being worth of $5,341,900. The most recent stock trade was executed by Martin P Sutter on 17 February 2022, trading 4,000 units of ABMD stock currently worth $1,258,840.
Abiomed Europe GmbH, Aachen / Germany, as affiliate of Abiomed Inc. headquartered in Danvers, Massachusetts, USA, is a leading medical technology company in the field of circulatory support. Its products aim to enable heart recovery by improving blood circulation and/or heart pump function.
Abiomed executives and other stock owners filed with the SEC include: